Literature DB >> 12597220

Idiopathic osteoarthritis of the hip: incidence, classification, and natural history of 272 cases.

George Hartofilakidis1, Theophilos Karachalios.   

Abstract

Long-term clinical and radiographic data of 210 patients (272 hips) with idiopathic hip osteoarthritis were reviewed. Of the 272 hips, 218 (80%) were eccentric and 54 (20%) were concentric. In eccentric hips, the femoral head migrated superolaterally or superomedially, because of the eccentric development of the degenerative changes, which had deteriorated rapidly. Hips with eccentric idiopathic osteoarthritis underwent total hip arthroplasty (THA) at an average of 4 years after symptom onset. In concentric hips, the femoral head migrated medially, causing progressive thinning of the medial wall of the acetabulum, and degenerative changes progressed slowly. Hips with concentric idiopathic osteoarthritis underwent THA at an average of 10 years after symptom onset.

Entities:  

Mesh:

Year:  2003        PMID: 12597220     DOI: 10.3928/0147-7447-20030201-18

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  4 in total

Review 1.  Systematic review of the prevalence of radiographic primary hip osteoarthritis.

Authors:  Simon Dagenais; Shawn Garbedian; Eugene K Wai
Journal:  Clin Orthop Relat Res       Date:  2008-11-27       Impact factor: 4.176

2.  Unilateral hip osteoarthritis: can we predict the outcome of the other hip?

Authors:  I C Vossinakis; G Georgiades; D Kafidas; G Hartofilakidis
Journal:  Skeletal Radiol       Date:  2008-07-23       Impact factor: 2.199

3.  Descriptive Epidemiology of Patients Undergoing Total Hip Arthroplasty in Korea with Focus on Incidence of Femoroacetabular Impingement: Single Center Study.

Authors:  Woo Yong Lee; Deuk Soo Hwang; Chang Kyun Noh
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

4.  Prognostic factors for progression of osteoarthritis of the hip: a systematic review.

Authors:  C H Teirlinck; D M J Dorleijn; P K Bos; J B M Rijkels-Otters; S M A Bierma-Zeinstra; P A J Luijsterburg
Journal:  Arthritis Res Ther       Date:  2019-08-23       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.